Download PDF
CC BY 4.0 · Rev Bras Ginecol Obstet 2022; 44(10): 915-924
DOI: 10.1055/s-0042-1756149
Original Article
High Risk Pregnacy

Inflammatory Bowel Disease and Pregnancy: Is It a Marker for Adverse Outcomes?

Doença inflamatória intestinal e gravidez: Será um marcador de desfechos adversos?
Rita Vicente Costa 
1   Gynecology and Obstetris Service, Hospital Distrital de Santarém, Santarém, Portugal
,
Carolina Simões 
2   Gastroenterology Service, Hospital de Santa Maria, Lisboa, Portugal
,
Luís Correia 
2   Gastroenterology Service, Hospital de Santa Maria, Lisboa, Portugal
,
Luísa Pinto 
3   Gynecology and Obstetrics Service, Hospital de Santa Maria, Lisboa, Portugal
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Objective To assess obstetric/puerperal/neonatal outcomes in an inflammatory bowel disease (IBD) population and to analyze disease characteristics that may be associated to adverse outcomes.

Methods Retrospective descriptive analysis including 47 pregnant women with IBD (28 with Crohn's disease – CD and 19 with ulcerative colitis – UC) who delivered between March 2012 and July 2018 in a tertiary hospital. We reviewed clinical records to extract demographic information, previous medical history, disease subtype, activity, severity, treatment, and obstetric, puerperal, and neonatal outcome measures.

Results Obstetric and neonatal complications (composite outcomes) occurred in 55.3% and 14.6% of the IBD population, respectively, and were more frequent in UC patients. Preterm birth (PTB), preeclampsia, anemia, low birth weight (LBW), and neonatal death were also more frequent in UC patients. The rate of postpartum hemorrhage (PPH) was 14.9%, and it was higher in CD patients. Women with active IBD had more obstetric/neonatal adverse outcomes (fetal growth restriction and LBW in particular) and cesarean sections. Patients with medicated IBD had less obstetric/neonatal complications (PTB and LBW in specific) and cesarean sections but more PPH.

Conclusion Women with IBD may have an increased risk of obstetric/puerperal/neonatal adverse outcomes. Ulcerative colitis patients had more obstetric and neonatal complications, whereas PPH was more frequent if CD patients. Other disease characteristics were considered, which allowed a better understanding of their possible influence. Although more research is needed, this work reinforces the importance of adequate surveillance to allow prompt recognition and treatment of complications.

Resumo

Objetivo Avaliar os desfechos obstétricos/puerperais/neonatais em uma população com doença inflamatória intestinal (DII) e analisar as características da doença, que podem estar associadas a desfechos adversos.

Métodos Análise descritiva retrospectiva incluindo 47 gestantes com DII (28 com doença de Crohn – DC e 19 com retocolite ulcerativa – RCU) que deram à luz entre março de 2012 e julho de 2018 em um hospital terciário. Revisamos os registros clínicos para extrair informações demográficas, histórico médico prévio, subtipo da doença, atividade, gravidade, tratamento e medidas de resultados obstétricos, puerperais e neonatais.

Resultados As complicações obstétricas e neonatais (desfechos compostos) ocorreram em 55,3% e 14,6% da população com DII, respectivamente; e foram mais frequentes em pacientes com RCU. Nascimento prematuro (PTB), pré-eclâmpsia, anemia, baixo peso ao nascer (BPN) e óbito neonatal também foram mais frequentes em pacientes com RCU. A taxa de hemorragia pós-parto (HPP) foi de 14,9% e foi maior em pacientes com DC. Mulheres com DII ativa tiveram mais desfechos obstétricos/neonatais adversos (restrição de crescimento fetal e BPN em particular) e cesarianas. Pacientes com DII medicada tiveram menos complicações obstétricas/neonatais (PTB e BPN em específico) e cesarianas, mas mais HPP.

Conclusão Mulheres com DII podem ter um risco aumentado de desfechos adversos obstétricos/puerperais/neonatais. As pacientes com RCU apresentaram mais complicações obstétricas e neonatais, enquanto a HPP foi mais frequente em pacientes com DC. Outras características da doença foram consideradas, o que permitiu uma melhor compreensão de sua possível influência. Embora mais pesquisas sejam necessárias, este trabalho reforça a importância de uma vigilância adequada para permitir o reconhecimento e o tratamento imediatos das complicações.

Keywords

inflammatory bowel diseases - pregnancy - retrospective studies

Palavras-chave

doenças inflamatórias intestinais - gravidez - estudos retrospectivos

Contributors

All authors were involved in the design and interpretation of the analyses, contributed to the writing of the manuscript, and read and approved the final manuscript.




Publication History

Received: 05 October 2021

Accepted: 21 June 2022

Article published online:
29 November 2022

© 2022. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5 (01) 17-30
    CrossrefPubMedSearch in Google Scholar
  • 2 Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133 (04) 1106-1112
    CrossrefPubMedSearch in Google Scholar
  • 3 Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M. et al; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohn's Colitis 2010; 4 (01) 63-101
    CrossrefPubMedSearch in Google Scholar
  • 4 Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK. et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56 (06) 830-837
    CrossrefPubMedSearch in Google Scholar
  • 5 Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009; 7 (03) 329-334
    CrossrefPubMedSearch in Google Scholar
  • 6 Bröms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol 2012; 10 (11) 1246-1252
    CrossrefPubMedSearch in Google Scholar
  • 7 Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR. European Crohn-Colitis Organisation (ECCO) Study Group of Epidemiologic Committee (EpiCom). Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther 2011; 34 (07) 724-734
    CrossrefPubMedSearch in Google Scholar
  • 8 Bröms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis 2014; 20 (06) 1091-1098
    CrossrefPubMedSearch in Google Scholar
  • 9 Getahun D, Fassett MJ, Longstreth GF, Koebnick C, Langer-Gould AM, Strickland D. et al. Association between maternal inflammatory bowel disease and adverse perinatal outcomes. J Perinatol 2014; 34 (06) 435-440
    CrossrefPubMedSearch in Google Scholar
  • 10 Tandon P, Govardhanam V, Leung K, Maxwell C, Huang V. Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease. Aliment Pharmacol Ther 2020; 51 (03) 320-333
    CrossrefPubMedSearch in Google Scholar
  • 11 Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990; 33 (10) 869-873
    CrossrefPubMedSearch in Google Scholar
  • 12 Nørgård B, Fonager K, Sørensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000; 95 (11) 3165-3170
    CrossrefPubMedSearch in Google Scholar
  • 13 Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008; 103 (05) 1203-1209
    CrossrefPubMedSearch in Google Scholar
  • 14 Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984; 6 (03) 211-216
    PubMedSearch in Google Scholar
  • 15 Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984; 25 (01) 52-56
    CrossrefPubMedSearch in Google Scholar
  • 16 Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986; 27 (07) 821-825
    CrossrefPubMedSearch in Google Scholar
  • 17 Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989; 160 (04) 998-1001
    CrossrefPubMedSearch in Google Scholar
  • 18 Nørgård B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007; 102 (09) 1947-1954
    CrossrefPubMedSearch in Google Scholar
  • 19 Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004; 15 (04) 237-241
    CrossrefPubMedSearch in Google Scholar
  • 20 Fonager K, Sørensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93 (12) 2426-2430
    CrossrefPubMedSearch in Google Scholar
  • 21 Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease–a population-based cohort study. Am J Obstet Gynecol 1997; 177 (04) 942-946
    CrossrefPubMedSearch in Google Scholar
  • 22 Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF. et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis 2011; 17 (03) 795-801
    CrossrefPubMedSearch in Google Scholar
  • 23 Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E. Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet 2005; 90 (03) 193-197
    CrossrefPubMedSearch in Google Scholar
  • 24 Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990; 99 (04) 987-994
    CrossrefPubMedSearch in Google Scholar
  • 25 Lin HC, Chiu CC, Chen SF, Lou HY, Chiu WT, Chen YH. Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol 2010; 105 (02) 387-394
    CrossrefPubMedSearch in Google Scholar
  • 26 Shand AW, Chen JS, Selby W, Solomon M, Roberts CL. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes. BJOG 2016; 123 (11) 1862-1870
    CrossrefPubMedSearch in Google Scholar
  • 27 Boyd HA, Basit S, Harpsøe MC, Wohlfahrt J, Jess T. Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS One 2015; 10 (06) e0129567
    CrossrefPubMedSearch in Google Scholar
  • 28 Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF. et al. Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010; 8 (06) 509-515
    CrossrefPubMedSearch in Google Scholar
  • 29 Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97 (03) 641-648
    CrossrefPubMedSearch in Google Scholar
  • 30 Nørgård B, Puho E, Pedersen L, Czeizel AE, Sørensen HT. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003; 98 (09) 2006-2010
    CrossrefPubMedSearch in Google Scholar
  • 31 Abdul Sultan A, West J, Ban L, Humes D, Tata LJ, Fleming KM. et al. Adverse pregnancy outcomes among women with inflammatory bowel disease: a population-based study from England. Inflamm Bowel Dis 2016; 22 (07) 1621-1630
    CrossrefPubMedSearch in Google Scholar
  • 32 Morales M, Berney T, Jenny A, Morel P, Extermann P. Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000; 47 (36) 1595-1598
    PubMedSearch in Google Scholar
  • 33 Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984; 19 (06) 724-732
    CrossrefPubMedSearch in Google Scholar
  • 34 Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18 (06) 735-742
    CrossrefPubMedSearch in Google Scholar
  • 35 de Lima-Karagiannis A, Zelinkova-Detkova Z, van der Woude CJ. The effects of active IBD during pregnancy in the Era of Novel IBD Therapies. Am J Gastroenterol 2016; 111 (09) 1305-1312
    CrossrefPubMedSearch in Google Scholar